Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M80,176Revenue $M26,095Net Margin (%)4.9Altman Z-Score2.0
Enterprise Value $M87,522EPS $1.0Operating Margin %8.6Piotroski F-Score3
P/E(ttm)64.0Beneish M-Score-2.9Pre-tax Margin (%)4.9Higher ROA y-yN
Price/Book4.510-y EBITDA Growth Rate %4.7Quick Ratio0.7Cash flow > EarningsY
Price/Sales3.15-y EBITDA Growth Rate %-16.2Current Ratio0.8Lower Leverage y-yN
Price/Free Cash Flow31.6y-y EBITDA Growth Rate %-34.0ROA % (ttm)2.2Higher Current Ratio y-yN
Dividend Yield %4.4PEG--ROE % (ttm)6.3Less Shares Outstanding y-yN
Payout Ratio %277Shares Outstanding M1,264ROIC % (ttm)8.1Gross Margin Increase y-yN

Gurus Latest Trades with AZN

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
AZNDavid Dreman 2015-03-31 Reduce-0.01%$64.44 - $72.7
($69.48)
$ 64.34-7%Reduce 4.43%27,489
AZNNWQ Managers 2015-03-31 Reduce-0.01%$64.44 - $72.7
($69.48)
$ 64.34-7%Reduce 21.34%52,265
AZNMario Gabelli 2015-03-31 Reduce$64.44 - $72.7
($69.48)
$ 64.34-7%Reduce 40.70%11,800
AZNDavid Dreman 2014-12-31 Reduce-0.51%$67.15 - $75.38
($71.66)
$ 64.34-10%Reduce 75.42%28,764
AZNGeorge Soros 2014-12-31 Sold Out -0.08%$67.15 - $75.38
($71.66)
$ 64.34-10%Sold Out0
AZNMario Gabelli 2014-12-31 Reduce-0.01%$67.15 - $75.38
($71.62)
$ 64.34-10%Reduce 52.51%19,900
AZNCharles Brandes 2014-09-30 Sold Out -0.35%$68.49 - $76.31
($73.2)
$ 64.34-12%Sold Out0
AZNCharles Brandes 2014-06-30 Reduce-0.78%$62.45 - $81.09
($72.26)
$ 64.34-11%Reduce 71.06%386,058
AZNJoel Greenblatt 2014-06-30 Sold Out -0.09%$62.45 - $81.09
($72.26)
$ 64.34-11%Sold Out0
AZNGeorge Soros 2014-06-30 Buy 0.08%$62.45 - $81.09
($72.26)
$ 64.34-11%New holding150,000
AZNMario Gabelli 2014-06-30 Buy 0.02%$62.45 - $81.09
($72.26)
$ 64.34-11%New holding40,400
AZNNWQ Managers 2014-06-30 Reduce-0.01%$62.45 - $81.09
($72.26)
$ 64.34-11%Reduce 24.55%64,475
AZNHOTCHKIS & WILEY 2014-03-31 Sold Out -0.93%$58.51 - $68.38
($64.41)
$ 64.34-0%Sold Out0
AZNCharles Brandes 2014-03-31 Reduce-0.84%$58.51 - $68.15
($64.29)
$ 64.340%Reduce 46.73%1,333,894
AZNDavid Dreman 2014-03-31 Add0.14%$58.51 - $68.38
($64.41)
$ 64.34-0%Add 26.61%135,439
AZNJoel Greenblatt 2014-03-31 Buy 0.09%$58.51 - $68.38
($64.41)
$ 64.34-0%New holding95,518
AZNDavid Dreman 2013-12-31 Reduce-0.34%$49.72 - $59.5
($54.28)
$ 64.3419%Reduce 40.32%106,975
AZNHOTCHKIS & WILEY 2013-12-31 Reduce-0.3%$49.72 - $59.5
($54.28)
$ 64.3419%Reduce 24.90%3,689,214
AZNCharles Brandes 2013-09-30 Add0.12%$47.88 - $52.08
($50.24)
$ 64.3428%Add 7.92%2,381,040
AZNHOTCHKIS & WILEY 2013-06-30 Add0.68%$47.22 - $53.01
($50.92)
$ 64.3426%Add 131.18%4,944,742
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

AZN is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


AZN: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
ASTRAZENECA PLC10% Owner 2014-11-12Sell2,000,000$17273.12view

Quarterly/Annual Reports about AZN:

    News about AZN:

    Articles On GuruFocus.com
    Last Month Insiders Bought Over $300 Million Of This Biotech Jun 26 2015 
    Guru Stocks at 52-Week Lows: XOM, WMT, CVX, AZN, COP Jun 21 2015 
    Amgen And AstraZeneca’s Deal On Psoriasis Drug Faces Termination May 27 2015 
    Johnson & Johnson A Good Investment Despite Current Lows May 14 2015 
    Vanguard Adds to Four of Its Largest Stakes May 04 2015 
    HealthCare Stocks That Can Make Investors Healthier Apr 08 2015 
    Regulus Therapeutics (RGLS) microRNA Therapeutic Milestone Payment, Dave & Buster's Entertainment (P Apr 08 2015 
    Pfizer Stocks Has A Lot Of Steam To Take The Investors Higher Jan 20 2015 
    Merck Takes A Step Forward In The World Of Medicine Jan 16 2015 
    Brandes International Equity Fund Q3 Commentary Dec 23 2014 

    More From Other Websites
    10:18 am AstraZeneca and Eolas Therapeutics enter into a worldwide license and partnership agreement... Jun 30 2015
    Why I’m Buying More AstraZeneca plc As It Hits A 52-Week Low Jun 30 2015
    4 Stocks That Are Trading Far, Far Too Cheaply: AstraZeneca plc, Old Mutual plc, Aberdeen Asset... Jun 26 2015
    HSBC initiates coverage of European pharmaceuticals Astra, GSK, Hikma and Shire Jun 26 2015
    Boris Johnson to suggest creating a "megafund" for biotech firms Jun 25 2015
    Why Vectura Group PLC Could Be The Perfect Partner For AstraZeneca plc In Your Portfolio Jun 25 2015
    AstraZeneca loses second top executive as Vectura gets new CEO Jun 24 2015
    Vectura Group appoints AstraZeneca executive as CEO Jun 24 2015
    Redx Pharma enjoys good progress during first-half Jun 22 2015
    Lions Health Announces Winners Jun 21 2015
    AstraZeneca appoints Pam Cheng as Executive Vice President, Operations and IT Jun 18 2015
    Chi-Med Arthritis Drug Spurs Interest From Potential Partners Jun 18 2015
    Is Alliance Pharma plc The Perfect Partner For AstraZeneca plc In Your Portfolio? Jun 18 2015
    Should You Buy These High-Yielding Shares? HSBC Holdings plc, AstraZeneca plc & Laura Ashley... Jun 16 2015
    AstraZeneca appoints Pam Cheng as Executive Vice President, Operations and IT Jun 16 2015
    AstraZeneca Presents Phase III Data on Gout Drug Lesinurad - Analyst Blog Jun 15 2015
    AstraZeneca presents new positive phase III data on triple therapy approach with dapagliflozin,... Jun 15 2015
    Looking For Pounding Payout Potential? Check Out AstraZeneca plc, Kier Group plc, Marston’s PLC &... Jun 15 2015
    AstraZeneca R&D executive Morrison to lead cancer firm Syndax Jun 15 2015
    AstraZeneca R&D executive Morrison to lead cancer firm Syndax Jun 15 2015

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    FEEDBACK